J.Y. Blay

Discipline

Psychologie (1) Education (1) Economies et finances (1)

Type de document

Articles (11) Recensions (5)

Co-auteur

Date

Source

Mot-clé

Treatment (9) Patients (9) Patients (9) Cancer (6) thérapie (5) cancer (5) taux (5) survie (5) Surgery (5) Cancer (5) Methods (5) Therapeutics (5) Survival (5) Surgery (5) Sarcoma (5) French (5) Methods (5) tissu (corporel) (4) maladie (4) procès (4) Impact (4) Use (4) maladie (4) sécurité (3) risque (3) oncologie (3) analyse (3) point (3) Diagnosis (3) Chemotherapy (3)

Documents écrit par J.Y. Blay (11) | parle de J.Y. Blay (0)

Guiding principles on the education and practice of theranostics.
TNB Pascual et al.
Improved nationwide survival of sarcoma patients with a network of reference centers
J.Y. Blay et al. (20 janv. 2024)
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
S. Stacchiotti et al.
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
D. Tougeron et al.
Vaccination contre la COVID-19 des patients atteints de cancer solide : revue et préconisations d’un inter-groupe oncologique français (CGO, TNCD, UNICANCER) [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]
D. Tougeron et al.
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
J. Bogaerts et al. (2015)
Classification of current anticancer immunotherapies.
L. Galluzzi et al. (2014)
Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.
T.K. Huynh et al. (2014)
Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure.
G.D. Demetri et al. (2012)
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.
A. Italiano et al. (2009)
Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?
S. Bonvalot et al. (2005)